The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice

Ingo Hilgendorf; Sara Eisele; Imke Remer; Jochen Schmitz; Katharina Zeschky; Christian Colberg; Peter Stachon; Dennis Wolf; Florian Willecke; Maike Buchner; Katja Zirlik; Alexandra Ortiz-Rodriguez; Andrey Lozhkin; Natalie Hoppe; Constantin von zur Muhlen; Axel zur Hausen; Christoph Bode; Andreas Zirlik

doi:10.1161/ATVBAHA.111.230847

The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice

Ingo Hilgendorf, Sara Eisele, Imke Remer, Jochen Schmitz, Katharina Zeschky, Christian Colberg, Peter Stachon, Dennis Wolf, Florian Willecke, Maike Buchner, Katja Zirlik, Alexandra Ortiz-Rodriguez, Andrey Lozhkin, Natalie Hoppe, Constantin von zur Muhlen, Axel zur Hausen, Christoph Bode, Andreas Zirlik^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

42 Citations (Web of Science)

Original language	English
Pages (from-to)	1991-U209
Journal	Arteriosclerosis Thrombosis and Vascular Biology
Volume	31
Issue number	9
DOIs	https://doi.org/10.1161/ATVBAHA.111.230847
Publication status	Published - Sep 2011

Keywords

atherosclerosis
macrophages
signal transduction
vascular biology
SYK

Access to Document

10.1161/ATVBAHA.111.230847

Cite this

Hilgendorf, I., Eisele, S., Remer, I., Schmitz, J., Zeschky, K., Colberg, C., Stachon, P., Wolf, D., Willecke, F., Buchner, M., Zirlik, K., Ortiz-Rodriguez, A., Lozhkin, A., Hoppe, N., von zur Muhlen, C., zur Hausen, A., Bode, C., & Zirlik, A. (2011). The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice. Arteriosclerosis Thrombosis and Vascular Biology, 31(9), 1991-U209. https://doi.org/10.1161/ATVBAHA.111.230847

Hilgendorf, Ingo ; Eisele, Sara ; Remer, Imke ; Schmitz, Jochen ; Zeschky, Katharina ; Colberg, Christian ; Stachon, Peter ; Wolf, Dennis ; Willecke, Florian ; Buchner, Maike ; Zirlik, Katja ; Ortiz-Rodriguez, Alexandra ; Lozhkin, Andrey ; Hoppe, Natalie ; von zur Muhlen, Constantin ; zur Hausen, Axel ; Bode, Christoph ; Zirlik, Andreas. / The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice. In: Arteriosclerosis Thrombosis and Vascular Biology. 2011 ; Vol. 31, No. 9. pp. 1991-U209.

@article{6dd503dcec00417ca4c9270f36ebed96,

title = "The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice",

keywords = "atherosclerosis, macrophages, signal transduction, vascular biology, SYK",

author = "Ingo Hilgendorf and Sara Eisele and Imke Remer and Jochen Schmitz and Katharina Zeschky and Christian Colberg and Peter Stachon and Dennis Wolf and Florian Willecke and Maike Buchner and Katja Zirlik and Alexandra Ortiz-Rodriguez and Andrey Lozhkin and Natalie Hoppe and {von zur Muhlen}, Constantin and {zur Hausen}, Axel and Christoph Bode and Andreas Zirlik",

year = "2011",

month = sep,

doi = "10.1161/ATVBAHA.111.230847",

language = "English",

volume = "31",

pages = "1991--U209",

journal = "Arteriosclerosis Thrombosis and Vascular Biology",

issn = "1079-5642",

publisher = "LIPPINCOTT WILLIAMS & WILKINS",

number = "9",

}

Hilgendorf, I, Eisele, S, Remer, I, Schmitz, J, Zeschky, K, Colberg, C, Stachon, P, Wolf, D, Willecke, F, Buchner, M, Zirlik, K, Ortiz-Rodriguez, A, Lozhkin, A, Hoppe, N, von zur Muhlen, C, zur Hausen, A, Bode, C & Zirlik, A 2011, 'The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice', Arteriosclerosis Thrombosis and Vascular Biology, vol. 31, no. 9, pp. 1991-U209. https://doi.org/10.1161/ATVBAHA.111.230847

The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice. / Hilgendorf, Ingo; Eisele, Sara; Remer, Imke; Schmitz, Jochen; Zeschky, Katharina; Colberg, Christian; Stachon, Peter; Wolf, Dennis; Willecke, Florian; Buchner, Maike; Zirlik, Katja; Ortiz-Rodriguez, Alexandra; Lozhkin, Andrey; Hoppe, Natalie; von zur Muhlen, Constantin; zur Hausen, Axel; Bode, Christoph; Zirlik, Andreas.

In: Arteriosclerosis Thrombosis and Vascular Biology, Vol. 31, No. 9, 09.2011, p. 1991-U209.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice

AU - Hilgendorf, Ingo

AU - Eisele, Sara

AU - Remer, Imke

AU - Schmitz, Jochen

AU - Zeschky, Katharina

AU - Colberg, Christian

AU - Stachon, Peter

AU - Wolf, Dennis

AU - Willecke, Florian

AU - Buchner, Maike

AU - Zirlik, Katja

AU - Ortiz-Rodriguez, Alexandra

AU - Lozhkin, Andrey

AU - Hoppe, Natalie

AU - von zur Muhlen, Constantin

AU - zur Hausen, Axel

AU - Bode, Christoph

AU - Zirlik, Andreas

PY - 2011/9

Y1 - 2011/9

KW - atherosclerosis

KW - macrophages

KW - signal transduction

KW - vascular biology

KW - SYK

U2 - 10.1161/ATVBAHA.111.230847

DO - 10.1161/ATVBAHA.111.230847

M3 - Article

C2 - 21700926

VL - 31

SP - 1991-U209

JO - Arteriosclerosis Thrombosis and Vascular Biology

JF - Arteriosclerosis Thrombosis and Vascular Biology

SN - 1079-5642

IS - 9

ER -